Showing results (71-80 of 150) with videos related to
Sort By:
Pageof 15
Molecular Cancer Research : MCR|June 24, 2010
Combining the FLT3 inhibitor PKC412 and the triterpenoid CDDO-Me synergistically induces apoptosis in acute myeloid leukemia with the internal tandem duplication mutationRehan Ahmad, Suiyang Liu, Ellen Weisberg, et al.Journal of Translational Medicine|September 12, 2015
Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosisCatriona Jamieson, Robert Hasserjian, Jason Gotlib, et al.The Australian Journal of Rural Health|December 10, 2025
Emergency Department Fascia Iliaca Block Catheters: A Safe and Feasible Pathway to Hip Fracture AnalgesiaRuth Miriam Blank, Sebastiaan Paul Blank, Phuong Markman, et al.Oncotarget|January 5, 2018
Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibitionEllen L Weisberg, Martin Sattler, Abdel Kareem Azab, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemiaMitch Raponi, Jean-Luc Harousseau, Jeffrey E Lancet, et al.Oncotarget|June 4, 2016
MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemiaAshujit Tagde, Hasan Rajabi, Dina Stroopinsky, et al.Blood|November 15, 2008
Protein disulfide isomerases are antibody targets during immune-mediated tumor destructionCatia Fonseca, Robert Soiffer, Vincent Ho, et al.Blood|November 28, 2013
MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cellsSuiyang Liu, Li Yin, Dina Stroopinsky, et al.Leukemia & Lymphoma|October 15, 2016
Incidence rates of treatment-emergent adverse events and related hospitalization are reduced with azacitidine compared with conventional care regimens in older patients with acute myeloid leukemiaJohn F Seymour, Hartmut Döhner, Mark D Minden, et al.Bioengineering & Translational Medicine|September 11, 2023
Quatramer™ encapsulation of dual-targeted PI3-Kδ/HDAC6 inhibitor, HSB-510, suppresses growth of breast cancerSachchidanand Tiwari, Suiyang Liu, Mohd Anees, et al.Pageof 15